NCT07646912Not yet recruiting
Effect of High-Intensity Focused Electromagnetic Therapy on Balance and Quality of Life in Patients With Multiple Sclerosis
Effect of High-Intensity Focused Electromagnetic Technology on Balance and Quality of Life in Patients With Multiple Sclerosis: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 15 Jun 2026
Brief summary (registry, in English)
Evaluate the effect of High-Intensity Focused Electromagnetic Therapy on dynamic balance, fall risk, core muscle function, and quality of life in patients with multiple sclerosis.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 9 Jun 2026
- Start date
- 22 Jun 2026
- Primary completion date
- 8 Oct 2026
- Lead sponsor
- Middle East University
- Diseases
- Multiple sclerosis
- NCT number
- NCT07646912
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 22 Jun 2026 to the primary completion date, 8 Oct 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Presence of pacemakers, internal defibrillators, or metallic implants in the torso/abdominal region.
- Other concomitant neurological or musculoskeletal orthopedic conditions that independently affect balance or gait.
Other illness
- Severe cognitive impairment interfering with the understanding of instructions or questionnaires.
- Severe visual deficits or uncorrected vestibular disorders.
Other
- Pregnancy.
Who the study is looking for
- Confirmed clinical diagnosis of Multiple Sclerosis according to the revised McDonald criteria.
- Expanded Disability Status Scale score range between 3.0 and 5.5.
- Clinically stable condition with no neurological relapses or corticosteroid therapy within the past 3 months.
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.